Oyster Point Pharma Dirección
Dirección controles de criterios 4/4
Información clave
Jeff Nau
Chief Executive Officer (CEO)
US$2.8m
Compensación total
| Porcentaje del salario del CEO | 20.1% |
| Permanencia del CEO | 5.3yrs |
| Participación del CEO | 0.3% |
| Permanencia media de la dirección | 2.1yrs |
| Promedio de permanencia en la Junta Directiva | 3.9yrs |
Actualizaciones recientes de la dirección
Recent updates
Is Oyster Point Pharma (NASDAQ:OYST) Using Debt In A Risky Way?
Nov 08
Oyster Point's nasal spray to be covered by largest Medicare pharmacy benefit manager
Aug 17Oyster Point Pharma, Inc. (NASDAQ:OYST) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Aug 14Oyster Point stock rises 11% after H.C. Wainwright begins coverage with Buy rating
Jul 18Oyster Therapeutics: State Of Business Is Confounding
Jun 30Is Oyster Point Pharma (NASDAQ:OYST) Using Debt In A Risky Way?
Dec 24Oyster Point Pharma (NASDAQ:OYST) Is In A Good Position To Deliver On Growth Plans
Oct 15Oyster Point Pharma starts enrollment in mid-stage Neurotrophic Keratopathy study
Jun 21Here's Why We're Not Too Worried About Oyster Point Pharma's (NASDAQ:OYST) Cash Burn Situation
May 10Need To Know: Oyster Point Pharma, Inc. (NASDAQ:OYST) Insiders Have Been Buying Shares
Feb 09
Oyster Point Pharma files US application for its lead program in dry eye disease
Dec 18Companies Like Oyster Point Pharma (NASDAQ:OYST) Are In A Position To Invest In Growth
Dec 18Oyster Point Pharma, Inc. 2020 Q3 - Results - Earnings Call Presentation
Nov 06Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2022 | n/a | n/a | -US$177m |
| Jun 30 2022 | n/a | n/a | -US$158m |
| Mar 31 2022 | n/a | n/a | -US$130m |
| Dec 31 2021 | US$3m | US$563k | -US$101m |
| Sep 30 2021 | n/a | n/a | -US$81m |
| Jun 30 2021 | n/a | n/a | -US$79m |
| Mar 31 2021 | n/a | n/a | -US$73m |
| Dec 31 2020 | US$6m | US$530k | -US$71m |
| Sep 30 2020 | n/a | n/a | -US$68m |
| Jun 30 2020 | n/a | n/a | -US$63m |
| Mar 31 2020 | n/a | n/a | -US$58m |
| Dec 31 2019 | US$4m | US$390k | -US$46m |
| Sep 30 2019 | n/a | n/a | -US$30m |
| Jun 30 2019 | n/a | n/a | -US$25m |
| Mar 31 2019 | n/a | n/a | -US$17m |
| Dec 31 2018 | US$390k | US$300k | -US$17m |
Compensación vs. Mercado: Jeff's total compensation ($USD2.80M) is about average for companies of similar size in the US market ($USD2.86M).
Compensación vs. Ingresos: Jeff's compensation has been consistent with company performance over the past year.
CEO
Jeff Nau (47 yo)
5.3yrs
Permanencia
US$2,803,339
Compensación
Dr. Jeffrey Nau, also known as Jeff, Ph. D, M. M. S, has been President, Chief Executive Officer and Director at Oyster Point Pharma, Inc since October 2017. Dr. Nau served as Vice President of Clinical an...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 5.3yrs | US$2.80m | 0.31% $ 933.1k | |
| CFO & Chief Business Officer | 3.5yrs | US$1.88m | 0.20% $ 605.7k | |
| Senior VP of CMC & Operations | 2.2yrs | sin datos | sin datos | |
| Chief Scientific Officer | 2.1yrs | sin datos | sin datos | |
| VP of Investor relations | no data | sin datos | sin datos | |
| Senior VP & General Counsel | 1.2yrs | sin datos | sin datos | |
| Chief Compliance & Privacy Officer | 1.2yrs | sin datos | sin datos | |
| Vice President of Communications & Public Relations | less than a year | sin datos | sin datos | |
| Chief Human Resources Officer | less than a year | sin datos | sin datos | |
| Senior Vice President of Regulatory Affairs | 2.2yrs | sin datos | sin datos | |
| Chief Medical Officer of Medical Affairs | 2.1yrs | sin datos | sin datos | |
| Senior VP & Head of Commercial | less than a year | sin datos | sin datos |
2.1yrs
Permanencia media
Equipo directivo experimentado: OYST's management team is considered experienced (2.1 years average tenure).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 5.3yrs | US$2.80m | 0.31% $ 933.1k | |
| Independent Director | 2.3yrs | US$176.43k | 0.048% $ 144.8k | |
| Independent Director | 5.5yrs | US$207.32k | 0.037% $ 112.4k | |
| Independent Director | 3.3yrs | US$167.49k | 0.12% $ 370.7k | |
| Non-Executive Chairperson | 1.5yrs | US$354.47k | 0.012% $ 35.5k | |
| Director | 5.3yrs | US$158.56k | 0.44% $ 1.3m | |
| Independent Director | 3.9yrs | US$171.43k | 0.037% $ 112.4k | |
| Independent Director | 3.9yrs | US$167.71k | 0.041% $ 123.6k | |
| Independent Director | 1.8yrs | US$553.37k | 0.043% $ 131.4k |
3.9yrs
Permanencia media
52.5yo
Promedio de edad
Junta con experiencia: OYST's board of directors are considered experienced (3.9 years average tenure).